Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 95, Issue 2, 2003, Pages 213-221

  Meer, Shabnum ^a,b   Galpin, Jacqueline S ^a   Altini, Mario ^a   Coleman, Hedley ^a   Ali, Hasiena ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; KI 67 ANTIGEN;

AMELOBLASTOMA; ARTICLE; CELL COUNT; CELL PROLIFERATION; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CYST; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; EVALUATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; SOLID STATE; SOLID TUMOR; STATISTICAL ANALYSIS; TISSUE SECTION; ANALYSIS OF VARIANCE; CELL DIVISION; CHEMISTRY; JAW TUMOR; OBSERVER VARIATION; PATHOLOGY;

AMELOBLASTOMA; ANALYSIS OF VARIANCE; CELL DIVISION; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; KI-67 ANTIGEN; OBSERVER VARIATION; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 0037518113     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2003.62     Document Type: Article

References (28)

1. Leider AS, Eversole LR, Barkin ME. Cystic ameloblastoma: a clinicopathologic analysis. Oral Surg Oral Med Oral Pathol 1985;60:624-30.
2. Eversole LR, Leider AS, Strub D. Radiographic characteristics of cystogenic ameloblastoma. Oral Surg Oral Med Oral Pathol 1984;57:572-7.
3. Gardner DG, Corio RL. Plexiform unicystic ameloblastoma: a variant of ameloblastoma with a low-recurrence rate after enucleation. Cancer 1984;53:1730-5.
4. Reichart PA, Philipsen HP, Sonner S. Ameloblastoma: biological profile of 3677 cases. Oral Oncol, Eur J Cancer 1995;31B:86-99.
5. Philipsen HP, Reichart PA. Unicystic ameloblastoma: a review of 193 cases from the literature. Oral Oncol, Eur J Cancer 1998;34:317-25.
6. Li T-J, Wu Y-T, Yu S-F, Yu G-Y. Unicystic ameloblastoma: a clinicopathologic study of 33 Chinese patients. Am J Surg Pathol 2000;24:1385-92.
7. Ueno S, Mushimoto K, Shirasu R. Prognostic evaluation of ameloblastomas based on histologic and radiographic typing. J Oral Maxillofac Surg 1989;47:11-5.
8. Sehdev MK, Huvos AG, Strong EW, Gerold FP, Willis GW. Proceedings: ameloblastoma of maxilla and mandible. Cancer 1974;33:324-33.
9. Ramanathan K, Chelvanayagam PI, Ramanathan J. Ameloblastomas - a clinicopathologic study of 133 cases in peninsular Malaysia. Med J Malaysia 1982;37:18-24.
10. Li T-J, Browne RM, Matthews JB. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 1995;26:219-28.
11. Slootweg PJ. p53 protein and Ki-67 reactivity in epithelial odontogenic lesions: an immunohistochemical study. J Oral Pathol Med 1995;24:393-7.
12. Tilakaratne W, Odell E, Lock C, Morgan P. Cell proliferation in odontogenic tumors [abstract]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88:210.
13. Tsai ST, Jin YT. Proliferating cell nuclear antigen (PCNA) expression in oral squamous cell carcinomas. J Oral Pathol Med 1995;24:313-5.
14. Van Diest PJ, Brugal G, Baak JPA. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 1998;51:716-24.
15. Tsuji T, Mimura Y, Wen S, Li X, Kanekawa A, Sasaki K, et al. The significance of PCNA and p53 protein in some oral tumors. Int J Oral Maxillofac Surg 1995;24:221-5.
16. Mighell A. Proliferating cell nuclear antigen [letter]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1995;80:3-4.
17. Brown DC, Gatter KC. Ki67 protein: the immaculate deception? Histopathology 2002;40:2-11.
18. Van Oijen MGCT, Medema RH, Slootweg PJ, Rijksen G. Positivity of the proliferation marker Ki-67 in noncycling cells. Am J Clin Pathol 1998;110:24-31.
19. Rudolph P, Peters J, Lorenz D, Schmidt D, Parwaresch R. Correlation between mitotic and Ki-67 labeling indices in paraffin-embedded carcinoma specimens. Hum Pathol 1998;29:1216-22.
20. Gardner DG. A pathologist's approach to the treatment of ameloblastoma. J Oral Maxillofac Surg 1984;42:161-6.
21. Ackermann GL, Altini M, Shear M. The unicystic ameloblastoma: a clinicopathological study of 57 cases. J Oral Pathol 1988;17:541-6.
22. Brown DC, Gatter KC. Monoclonal antibody Ki-67: its use in histopathology. Histopathology 1990;17:489-503.
23. Kim J, Yook JI. Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Oral Oncol, Eur J Cancer 1994;30B:126-31.
24. Piattelli A, Fioroni M, Santinelli A, Rubini C. Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 1998;34:408-12.
25. Funaoka K, Arisue M, Kobayashi I, Iizuka T, Kohgo T, Amemiya A, et al. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma. Oral Oncology, Eur J Cancer 1996;32B:328-32.
26. Ong'uti MN, Cruchley AT, Howells GL, Williams DM. Ki-67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya. Int J Oral Maxillofac Surg 1997;26:376-9.
27. Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y, Ohishi M. Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol 2001;37:193-8.
28. Rosenstein T, Pogrel MA, Smith RA, Regezi JA. Cystic ameloblastoma-behavior and treatment of 21 cases. J Oral Maxillofac Surg 2001;59:1311-6.